| PE11.18 | Epidemiology and genetic diversity of HIV-1 variants detected among HIV-infected individuals in Old Cross River State, Nigeria | E-poster | Epidemiology of HIV |
| PE11.19LB | Phylodynamic analysis of HIV-1 non-B subtypes suggests divergent North and South American virus lineages | E-poster | Epidemiology of HIV |
| PE12.01 | Integration of gender-based violence screening and support into the research clinic setting: experiences from an HIV prevention open label extension trial in sub-Saharan Africa | E-poster | Ethics in HIV prevention research |
| PE12.02 | 'It's almost as if stakeholder engagement is the annoying 'have-to-do…' recognizing 'tokenism' in stakeholder engagement - Perceptions of key role-players in HIV prevention | E-poster | Ethics in HIV prevention research |
| PE13.01 | What happened to my stock? Management and tracking of HIV self-testing (HIV-ST) kit distribution in rural KwaZulu-Natal | E-poster | High-throughput datasets in prevention science |
| PE14.01 | Broadly neutralizing plasma antibodies effective against diverse autologous circulating viruses in infants with multivariant HIV-1 infection | E-poster | HIV sequencing insights including viral diversity and antiretroviral resistance |
| PE14.02 | HIV drug resistance assessment among seroconverters from the MTN-025/HOPE Open-Label Dapivirine Vaginal Ring Study | E-poster | HIV sequencing insights including viral diversity and antiretroviral resistance |
| PE15.01 | Transient Viral Exposures Drive Humoral Responses in HIV-1 Post-Treatment Controllers | E-poster | HIV sequencing insights including viral diversity and antiretroviral resistance |
| PE15.03 | Analysis of IgG1 and IgG3 humoral response against the membrane proximal external region of HIV-1 envelope glycoprotein | E-poster | Humoral immunity |
| PE15.04 | Association of HIV vaccine construct and VISP/R in 70 HIV vaccine trials | E-poster | Humoral immunity |